Literature DB >> 11413947

Preventing depression in high-risk college women: a report of an 18-month follow-up.

A R Peden1, M K Rayens, L A Hall, L H Beebe.   

Abstract

The authors tested the long-term effectiveness of a cognitive-behavioral group intervention in reducing depressive symptoms, decreasing negative thinking, and enhancing self-esteem in 92 college women aged 18 to 24 years who ere at risk for clinical depression. The women were randomly assigned to either an experimental or a no-treatment control group. The experimental group participated in a 6-week cognitive-behavioral intervention that targeted identification and reduction of negative thinking, using such techniques as thought stopping and affirmations. Data on depressive symptoms, self-esteem, and negative thinking were collected before the intervention and at intervals of 1, 6, and 18 months postintervention. The women in the intervention group experienced a greater decrease in depressive symptoms and negative thinking and a greater increase in self-esteem than those in the control group. The beneficial effects continued over an 18-month follow-up period. These findings support the importance of thought stopping and affirmations as prevention interventions with at-risk college women.

Entities:  

Mesh:

Year:  2001        PMID: 11413947     DOI: 10.1080/07448480109596316

Source DB:  PubMed          Journal:  J Am Coll Health        ISSN: 0744-8481


  10 in total

1.  Outcomes of Depression in Black Single Mothers.

Authors:  Rahshida L Atkins
Journal:  Clin Nurs Res       Date:  2016-02-24       Impact factor: 2.075

2.  A longitudinal pilot study of depressive symptoms in concussed and injured/nonconcussed National Collegiate Athletic Association Division I student-athletes.

Authors:  Trevor Roiger; Lee Weidauer; Bryce Kern
Journal:  J Athl Train       Date:  2015-01-06       Impact factor: 2.860

Review 3.  Community-based prevention programs for anxiety and depression in youth: a systematic review.

Authors:  Helen Christensen; Emma Pallister; Stephanie Smale; Ian B Hickie; Alison L Calear
Journal:  J Prim Prev       Date:  2010-06

Review 4.  Measurement of negative thinking in patients with heart failure: a critical review and analysis.

Authors:  Rebecca L Dekker
Journal:  J Cardiovasc Nurs       Date:  2011 Jan-Feb       Impact factor: 2.083

5.  Experimental test of the affect-regulation theory of bulimic symptoms and substance use: a randomized trial.

Authors:  Emily Burton; Eric Stice; Sarah Kate Bearman; Paul Rohde
Journal:  Int J Eat Disord       Date:  2007-01       Impact factor: 4.861

6.  Developing a shortened measure of negative thinking for use in patients with heart failure.

Authors:  Rebecca L Dekker; Terry A Lennie; Lynne A Hall; Ann R Peden; Misook L Chung; Debra K Moser
Journal:  Heart Lung       Date:  2011-02-15       Impact factor: 2.210

7.  Combined MI + CBT for Depressive Symptoms and Binge Drinking Among Young Adults: Two Case Studies.

Authors:  Paola Pedrelli; Brian Borsari; Kathleen M Palm; Elizabeth Dalton; Maurizio Fava
Journal:  J Cogn Psychother       Date:  2013-08-01

8.  A meta-analytic review of depression prevention programs for children and adolescents: factors that predict magnitude of intervention effects.

Authors:  Eric Stice; Heather Shaw; Cara Bohon; C Nathan Marti; Paul Rohde
Journal:  J Consult Clin Psychol       Date:  2009-06

9.  Effects of mental health interventions for students in higher education are sustainable over time: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Regina Winzer; Lene Lindberg; Karin Guldbrandsson; Anna Sidorchuk
Journal:  PeerJ       Date:  2018-04-02       Impact factor: 2.984

10.  A Web-Based Group Cognitive Behavioral Therapy Intervention for Symptoms of Anxiety and Depression Among University Students: Open-Label, Pragmatic Trial.

Authors:  Jason Bantjes; Alan E Kazdin; Pim Cuijpers; Elsie Breet; Munita Dunn-Coetzee; Charl Davids; Dan J Stein; Ronald C Kessler
Journal:  JMIR Ment Health       Date:  2021-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.